Changes in the urinary excretion of β2-microglobulin (β2MG) and N-acety-β-D-glucosaminidase (NAG) during treatment for lupus nephritis

Internal Medicine

Volumn 47, Issue 4, 2008, Pages 287-290

  Masuda, Takahiro ^a   Akimoto, Tetsu ^a   Ando, Yasuhiro ^a   Kobayashi, Takahisa ^a   Meguro, Daishi ^a   Muto, Shigeaki ^a   Ueda, Yoshihiko ^b   Yumura, Wako ^a   Kusano, Eiji ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

microglobulin; Double filtration plasmapheresis; Lupus nephritis; N acety beta D glucosaminidase; Tubulointerstitial nephritis

Indexed keywords

ANTINUCLEAR ANTIBODY; BETA 2 MICROGLOBULIN; CYCLOPHOSPHAMIDE; ETHYLENE VINYL ALCOHOL COPOLYMER; METHYLPREDNISOLONE; N ACETYL BETA GLUCOSAMINIDASE; POLYETHYLENE; PREDNISOLONE; SM ANTIBODY;

ADULT; ARTICLE; CASE REPORT; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; ELECTRON MICROSCOPY; HOSPITAL ADMISSION; HUMAN; KIDNEY BIOPSY; KIDNEY TUBULE DISORDER; LABORATORY TEST; LEG EDEMA; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PHOTOSENSITIVITY; PLASMAPHERESIS; POLYARTHRITIS; RASH; SUN EXPOSURE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; URINARY EXCRETION;

ACETYLGLUCOSAMINIDASE; AGED; BETA 2-MICROGLOBULIN; HUMANS; LUPUS NEPHRITIS; MALE;

EID: 40749098536     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0464     Document Type: Article

References (15)

1. Mistry-Burchardi N, Schönermarck U, Samtleben W. Apheresis in lupus nephritis. Ther Apher 5: 161-170, 2001.
2. Tsai CY, Wu TH, Yu CL, Lu JY, Tsai YY. Increased excretion of β2-microglobulin, IL-6, and IL-8 and decreased excretion of Tamm-Horsfall glycoprotein in urine of patients with active lupus nephritis. Nephron 85: 207-214, 2000.
3. O'Dell JR, Hays RC, Guggenheim SJ, Steigerwald JC. Tubulointerstitial renal disease in systemic lupus erythematosus. Arch Intern Med 145: 1996-1999, 1985.
4. Hayashi M, Ueda Y, Hoshimoto K, et al. Changes in urinary excretion of six biochemical parameters in normotensive pregnancy and preeclampsia. Am J Kidney Dis 39: 392-340, 2002.
5. Erdener D, Aksu K, Bicer I, Deganavsargil E, Kutay FZ. Urinary N-acetyl-β-D-glucosaminidase (NAG) in lupus nephritis and rheumatoid arthritis. J Clin Lab Anal 19: 172-176, 2005.
6. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1277, 1982.
7. Weening JJ, D'Agati VD, Schwartz MM, et al. International Society of Nephrology Working Group on the Classification of Lupus Nephritis; Renal Pathology Society Working Group on the Classification of Lupus Nephritis. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65: 521-530, 2004 (erratum in: Kidney Int 65: 1132, 2004).
8. Brentjens JR, Sepulveda M, Baliah T, et al. Interstitial immune complex nephritis in patients with systemic lupus erythematosus. Kidney Int 7: 342-350, 1975.
9. Toto RD. Acute tubulointerstitial nephritis. Am J Med Sci 299: 392-410, 1990.
10. Kuusniemi AM, Lapatto R, Holmberg C, Karikoski R, Rapola J, Jalanko H. Kidneys with heavy proteinuria show fibrosis, inflammation, and oxidative stress, but no tubular phenotypic change. Kidney Int 68: 121-132, 2005.
11. Hill GS, Delahousse M, Nochy D, Mander C, Bariety J. Proteinuria and tubulointerstitial lesions in lupus nephritis. Kidney Int 60: 1893-1903, 2001.
12. Singh AK, Ucci A, Madias NE. Predominant tubulointerstitial lupus nephritis. Am J Kidney Dis 27: 273-278, 1996.
13. Houssiau FA. Management of lupus nephritis: An update. J Am Soc Nephrol 15: 2694-2704, 2004.
14. Madore F, Lazarus JM, Brady HR. Therapeutic plasma exchange in renal disease:J Am Soc Nephrol 7: 367-386, 1997.
15. Laskus T, Cianciara J, Slusarczyk J. Follow-up study of an outbreak of non-A and non-B hepatitis in plasmapheresis unit. Liver 10: 49-53, 1990.